Evidence map›Paper›PMID 38979376›Full record

ArticlebioRxiv : the preprint server for biology2024

Islet-antigen reactive B cells display a unique phenotype and BCR repertoire in autoantibody positive and recent-onset type 1 diabetes patients.

Catherine A Nicholas, Fatima A Tensun, Spencer A Evans, Kevin P Toole, Hali Broncucia, Jay R Hesselberth, Peter A Gottlieb, Kristen L Wells, Mia J Smith

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Catherine A NicholasBarbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO 80045, USA.ORCID 0000-0003-2724-266X
Fatima A TensunBarbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Spencer A EvansBarbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Kevin P TooleBarbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Hali BroncuciaBarbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Jay R HesselberthDepartment of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO 80045, USA.ORCID 0000-0002-6299-179X
Peter A GottliebBarbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Kristen L WellsBarbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO 80045, USA.ORCID 0000-0002-7466-8164
Mia J SmithBarbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO 80045, USA.ORCID 0000-0003-3042-5061

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
University of Colorado Anschutz Medical Campus DRCP30DK116073 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LORI SUSSEL · 2020 to 2026
$10.8M
Predoctoral Training Program in Molecular and Cellular Biology (Supplement: Mentoring in the Research Environment)T32GM136444 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI MICHAEL A MCMURRAY, Rytis Prekeris · 2020 to 2026
$3.7M
Biochemistry at single-cell resolution: a new approach to understand functional heterogeneityR01AG071467 · NIA · UNIVERSITY OF COLORADO DENVER · PI HESSELBERTH, JAY R · 2020 to 2024
$3.2M
Genetic contribution to loss of B cell anergy during development of type 1 diabetesK01OD028759 · OD · UNIVERSITY OF COLORADO DENVER · PI SMITH, MIA · 2020 to 2024
$567k
Characterizing molecular phenotypes of pancreatic islet reactive B cells in T1D through single cell sequencingF31DK134095 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI NICHOLAS, CATHERINE A · 2023 to 2024
$67k
NCI NIH HHS P30 CA046934NIA NIH HHS R01 AG071467NIDDK NIH HHS F31 DK134095NIDDK NIH HHS P30 DK116073NIGMS NIH HHS T32 GM136444NIH HHS K01 OD028759
6 · The paper itself

Abstract

Autoreactive B cells play an important but ill-defined role in autoimmune type 1 diabetes (T1D). To better understand their contribution, we performed single cell gene and BCR-seq analysis on pancreatic islet antigen-reactive (IAR) B cells from the peripheral blood of nondiabetic (ND), autoantibody positive prediabetic (AAB), and recent-onset T1D individuals. We found that the frequency of IAR B cells was increased in AAB and T1D. IAR B cells from these donors had altered expression of B cell signaling, pro-inflammatory, infection, and antigen processing and presentation genes. Both AAB and T1D donors demonstrated a significant increase in certain heavy and light chain V genes, and these V genes were enriched in islet-reactivity. Public clones of IAR B cells were restricted almost entirely to AAB and T1D donors. IAR B cells were clonally expanded in the autoimmune donors, particularly the AAB group. Notably, a substantial fraction of IAR B cells in AAB and T1D donors appeared to be polyreactive, which was corroborated by analysis of recombinant monoclonal antibodies. These results expand our understanding of autoreactive B cell activation during T1D and identify unique BCR repertoire changes that may serve as biomarkers for increased disease risk.

Identifiers

PMID38979376
PMCPMC11230262

What Socratic holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.